Trial Profile
Clinical Trials Insight: 700056963
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2013
Price :
$35
*
At a glance
- Drugs Buspirone (Primary) ; Melatonin (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 27 May 2010 Results discussed at American Psychiatric Society (APA) meeting.
- 27 May 2010 New trial record